Lumata Health Strengthens Executive Leadership with Appointment of Chief Technology Officer and Chief Growth Officer to Drive Next Phase of Expansion
Lumata Health, a company dedicated to preventing avoidable blindness through continuous ophthalmic care, announced a significant expansion of its leadership team with the addition of two senior executives: Annu Singh as Chief Technology Officer (CTO) and Nastran Andersen as Chief Growth Officer (CGO). These strategic appointments underscore the company’s commitment to advancing its innovative, data-driven platform designed to improve treatment adherence among patients with chronic retinal diseases.
The appointments come at a critical time for Lumata Health, which is experiencing rapid growth as ophthalmologists, pharmaceutical partners, and patients increasingly turn to its continuous care model. By bringing in leaders with deep expertise in technology, healthcare operations, and business expansion, the company is positioning itself for its next stage of development—broadening its footprint, investing in artificial intelligence-enabled solutions, and strengthening its partnerships across the eye care ecosystem.
Meeting the Rising Demand for Continuous Ophthalmic Care
Chronic eye conditions such as diabetic retinopathy, macular degeneration, and other retinal diseases represent some of the most challenging and costly health burdens globally. Millions of patients require frequent, ongoing treatment to preserve their vision, yet adherence to prescribed therapies often remains suboptimal. Missed appointments, logistical barriers, lack of education, and treatment fatigue can all contribute to poor outcomes.
Lumata Health addresses this challenge head-on with its continuous care model. Using a predictive analytics platform, the company identifies patient needs between visits, anticipates potential barriers to adherence, and deploys ophthalmic technicians who provide support, education, and coordination. This model ensures that patients remain engaged with their prescribed treatment plans, ultimately helping to preserve their vision and prevent avoidable blindness.
“Preventable vision loss is one of the most pressing healthcare challenges we face today,” said Landon Grace, CEO of Lumata Health. “Our mission has always been to provide patients with the continuous support they need, beyond the clinic walls, so that they never fall through the cracks of the healthcare system. The leadership additions we’re announcing today will give us the talent and expertise necessary to accelerate our mission at scale.”
Annu Singh: Bringing Scalable Technology to Ophthalmic Care
Appointed as Chief Technology Officer, Annu Singh will lead Lumata Health’s technology strategy, product development, and platform execution. With over 25 years of experience building and scaling platforms for Fortune 500 and Global 5000 companies, Singh has a track record of launching innovative, patient-centered solutions that combine data-driven insights with adaptive, scalable architectures.
Throughout his career, Singh has overseen the development of technology platforms serving more than 15 million users across healthcare and education technology sectors. He has played instrumental roles in guiding organizations through multiple acquisitions totaling $600 million, as well as contributing to a public offering exceeding $1 billion. His experience in bringing digital platforms from concept to scale will be pivotal for Lumata Health as it invests in advanced technologies such as artificial intelligence and data-enabled care solutions.
“Joining Lumata Health is both an honor and a profound responsibility,” Singh said. “The opportunity to use technology to directly impact patients’ vision health and quality of life is incredibly meaningful. By building AI-enabled, data-driven tools, we can anticipate patient needs earlier, resolve barriers faster, and give clinicians the insights they need to deliver more effective care. The potential to transform chronic disease management in ophthalmology is immense, and I’m excited to be part of this journey.”
Nastran Andersen: Driving Growth Across Healthcare Markets
As Chief Growth Officer, Nastran Andersen brings nearly three decades of experience leading revenue growth and client success in the healthcare industry. Andersen has a proven ability to scale organizations by fostering collaboration across sales, marketing, and client-facing functions. She has worked with Fortune 10 and Fortune 500 companies, as well as private equity-backed firms and emerging healthcare businesses.
Her expertise spans diverse areas of the healthcare ecosystem, including provider organizations, health plans, post-acute care, and emerging fields such as new care delivery models and aging technology solutions. This breadth of experience equips her to guide Lumata Health’s expansion into new markets and deepen relationships with healthcare stakeholders.
“Lumata Health’s solution represents exactly what healthcare needs—proactive, patient-centered, and data-driven support that reduces barriers and improves outcomes,” Andersen noted. “The company has already demonstrated its ability to make a significant impact on vision care. My focus will be on ensuring that more patients, physicians, and partners can access these solutions as quickly as possible, while driving sustainable growth for the business.”
A Year of Expansion and Investment
The leadership additions follow a year of significant momentum for Lumata Health. The company has been scaling its proven adherence solution across new practices and expanding its partnerships with pharmaceutical companies focused on retinal therapies. At the same time, Lumata Health has continued to invest in its analytics platform, building capabilities that proactively identify risks to adherence before they become critical issues.
CEO Landon Grace emphasized that 2025 represents an inflection point for the company. “This year has been a period of remarkable expansion,” Grace said. “We’ve seen growing demand from physicians and healthcare partners who recognize that treatment adherence is essential for preventing vision loss. By strengthening our leadership team with exceptional talent like Annu and Nastran, we are better positioned than ever to deliver on this demand. As we scale, we will remain laser-focused on supporting patients, advancing technology, and ensuring that every individual with a vision-threatening disease receives the care they need.”
The Broader Impact of Lumata Health’s Mission
Vision loss and blindness carry profound personal, social, and economic consequences. Patients who lose their sight often face reduced independence, increased risk of accidents, and diminished quality of life. From a healthcare systems perspective, the costs associated with blindness—including hospitalizations, long-term care, and productivity loss—are substantial.
By improving treatment adherence in retinal disease management, Lumata Health is addressing a critical gap in the healthcare continuum. Its approach not only enhances patient outcomes but also generates significant economic value by preventing costly complications. The model exemplifies how data and technology can extend care beyond clinical settings, providing proactive support that strengthens the physician-patient relationship.
